Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
Plomgaard, Anne M.; Alderliesten, Thomas; Austin, Topun; van Bel, Frank; Benders, Manon; Claris, Olivier; Dempsey, Eugene M.; Fumagalli, Monica; Gluud, Christian; Hagmann, Cornelia; Hyttel-Sorensen, Simon; Lemmers, Petra; van Oeveren, Wim; Pellicer, Adelina; Petersen, Tue H.; Pichler, Gerhard; Winkel, Per; Greisen, Gorm
Date:
2017-03-22
Copyright:
© 2017, Plomgaard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Plomgaard, A. M., Alderliesten, T., Austin, T., van Bel, F., Benders, M., Claris, O., Dempsey, E., Fumagalli, M., Gluud, C., Hagmann, C., Hyttel-Sorensen, S., Lemmers, P., van Oeveren, W., Pellicer, A., Petersen, T. H., Pichler, G., Winkel, P. and Greisen, G. (2017) 'Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial', PLoS ONE, 12(3), e0173440 (15pp). doi: 10.1371/journal.pone.0173440
Abstract:
The randomized clinical trial, SafeBoosC II, examined the effect of monitoring of cerebral oxygenation by near-infrared spectroscopy combined with a guideline on treatment when cerebral oxygenation was out of the target range. Data on cerebral oxygenation was collected in both the intervention and the control group. The primary outcome was the reduction in the burden of cerebral hypo- and hyperoxia between the two groups. In this study we describe the associations between the burden of cerebral hypo- and hyperoxia, regardless of allocation to intervention or control group, and the biomarkers of brain injury from birth till term equivalent age that was collected as secondary and explorative outcomes in the SafeBoosC II trial.
Show full item record
Except where otherwise noted, this item's license is described as © 2017, Plomgaard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.